The proposed approach to treat APC mutated cancers is the use of G007-LK, LZZ-02, or RK-582 at low dosage in association with the PI3K (BKM120) and the epidermal growth factor receptor (EGFR) (erlotinib) inhibitors for colon cancer treatment [31,113]. Here, EGFR is linked to colonic neoplasm.